Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Amyloid Beta in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study

NCT01754168 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01754168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01754168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Amyloid Beta in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Completed
Start date
February 28, 2013
Completion date
February 28, 2018
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurological disorders, parkinson disease